Stonebridge Capital Advisors’s Boston Scientific BSX Stock Holding History

Stonebridge Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-91	Closed	-$4.8K	–	296
2023 Q3	$4.8K	Sell	91 -326	-78%	-$17.1K	﹤0.01%	711
2023 Q2	$22.6K	Sell	417 -89	-18%	-$4.65K	﹤0.01%	499
2023 Q1	$25.3K	Buy	506 +169	+50%	+$7.96K	﹤0.01%	471
2022 Q4	$15.6K	Buy	337 +284	+536%	+$12.3K	﹤0.01%	526
2022 Q3	$2K	Buy	+53	New	+$2.13K	﹤0.01%	786
2020 Q2	–	Sell	-95	Closed	-$3K	–	783
2020 Q1	$3K	Hold	95	–	–	﹤0.01%	596
2019 Q4	$4K	Buy	+95	New	+$3.98K	﹤0.01%	665

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stonebridge Capital Advisors's BSX Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 91 shares — an estimated $4.8K sold.

Stonebridge Capital Advisors first reported a position in BSX in Q4 2019 and held it in 7 quarters. The position peaked at $25.3K in Q1 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 91 Boston Scientific shares in Q4 2023, an estimated $4.8K.
Stonebridge Capital Advisors first reported a position in Boston Scientific in Q4 2019 and held it in 7 quarters.
Stonebridge Capital Advisors's Boston Scientific position peaked at $25.3K in Q1 2023.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.